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Extravasating leukocytes have to migrate 
through the blood vessel wall, a process called 
diapedesis. Several endothelial cell contact 
  proteins, such as platelet endothelial cell adhe-
sion molecule-1 (PECAM-1), members of the 
junctional adhesion molecule (JAM) family 
(JAM-A, JAM-B, and JAM-C), CD99, and 
ICAM-2, have been described to support leu-
kocyte diapedesis (1–4), although the detailed 
mechanisms by which they mediate this pro-
cess are not yet understood.
The endothelial cell–selective adhesion 
molecule (ESAM), although related to the JAM 
family members, diff  ers considerably in struc-
ture (5), cytosolic binding partners (6, 7), and 
tissue distribution. In contrast to the JAMs, ex-
pression of ESAM is strictly limited to endo-
thelial cells and platelets and cannot be found 
on leukocytes or epithelia (8). On platelets ESAM 
is only expressed upon activation, whereas 
on endothelial cells it is strictly restricted to 
tight junctions as was demonstrated by immuno-
gold labeling (8).
Recently, ESAM-defi  cient mice were de-
scribed to have defects in tumor angiogenesis, 
although embryonal angiogenesis was unaf-
fected (9). Because of its localization at endo-
thelial tight junctions, we decided to investigate 
a potential role of ESAM in leukocyte extrava-
sation. Here we show that migration of neu-
trophils into infl  amed peritoneum is delayed 
in ESAM-defi  cient mice, whereas the entry of 
lymphocytes into infl  amed skin was unaff  ected. 
Intravital microscopy revealed that it was the 
migration of leukocytes through the vessel 
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Endothelial cell–selective adhesion molecule (ESAM) is specifi  cally expressed at endothelial 
tight junctions and on platelets. To test whether ESAM is involved in leukocyte extravasa-
tion, we have generated mice carrying a disrupted ESAM gene and analyzed them in three 
different infl  ammation models. We found that recruitment of lymphocytes into infl  amed 
skin was unaffected by the gene disruption. However, the migration of neutrophils into 
chemically infl  amed peritoneum was inhibited by 70% at 2 h after stimulation, recovering 
at later time points. Analyzing neutrophil extravasation directly by intravital microscopy in 
the cremaster muscle revealed that leukocyte extravasation was reduced (50%) in ESAM−/− 
mice without affecting leukocyte rolling and adhesion. Depletion of >98% of circulating 
platelets did not abolish the ESAM defi  ciency–related inhibitory effect on neutrophil 
extravasation, indicating that it is only ESAM at endothelial tight junctions that is relevant 
for the extravasation process. Knocking down ESAM expression in endothelial cells resulted 
in reduced levels of activated Rho, a GTPase implicated in the destabilization of tight 
junctions. Indeed, vascular permeability stimulated by vascular endothelial growth factor 
was reduced in ESAM−/− mice. Collectively, ESAM at endothelial tight junctions partici-
pates in the migration of neutrophils through the vessel wall, possibly by infl  uencing endo-
thelial cell contacts.
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wall, the diapedesis process, which was impaired by the lack 
of ESAM. We could exclude ESAM on platelets as being rele-
vant for leukocyte extravasation and found that endothelial 
ESAM supports the activation of Rho. Because activated 
Rho supports the opening of tight junctions and because the 
increase of vascular endothelial growth factor (VEGF)-stimu-
lated vascular permeability was attenuated by the lack of 
ESAM, our results point toward a role of ESAM in the open-
ing of endothelial cell contacts.
RESULTS AND DISCUSSION
Generation of ESAM-defi  cient mice
The targeting construct to disrupt the ESAM gene was cre-
ated such that the coding sequences of exons 1 and 2 were 
replaced by a neomycin expression cassette leading to the 
  deletion of the start codon (Fig. 1 A). Southern blot analysis 
of DNA of the generated mice with an external probe as well 
as PCR genotyping revealed the expected results (Fig. 1, 
B and C). As determined in immunoblots of lung and heart 
tissue, heterozygous ESAM+/− mice showed reduced 
levels of ESAM protein expression, whereas the ESAM protein 
was undetectable with polyclonal antibodies in tissues of 
ESAM−/− mice (Fig. 1 D).
Heterozygous as well as homozygous mice backcrossed 
into the C57BL/6 background were viable and apparently 
normal. Mutant mice had a 10% reduction in weight in 
agreement with Ishida et al. (9). Absolute and diff  erential 
  leukocyte counts (determined for leukocytes stained for 
CD4, CD8, CD19, Gr-1, and F4-80 antigen) were normal.
ESAM is required for the recruitment of neutrophils, 
but not of lymphocytes, into infl  amed tissue
We have recently reported that polyclonal antibodies against 
ESAM did not block the migration of lymphocytes into 
  infl  amed skin in a delayed-type hypersensitivity model (3). 
However, these antibodies may not block functional epitopes 
of ESAM. To clarify the role of ESAM in lymphocyte 
  extravasation, we compared ESAM−/− and ESAM+/+  animals 
in the delayed-type hypersensitivity model. As shown in 
Fig. 2 A, dinitrofl  uorobenzene (DNFB)-elicited emigration 
of T cells at 15 and 5 h after injection of radioactively labeled 
T cells was similar between ESAM+/+ and ESAM−/− animals. 
No signifi  cant T cell emigration was detectable at 2 h after 
T cell inoculation (not depicted). Thus, ESAM is not re-
quired for the accumulation of lymphocytes into infl  amed 
skin. Neither the recruitment of CD4+ nor CD8+ T cells 
was aff  ected, as was analyzed by immunohistochemistry 
(not depicted).
Using the thioglycollate-induced peritonitis model, we 
tested whether neutrophil accumulation in the peritoneum 
would be aff  ected by the lack of ESAM. Comparing the 
number of neutrophils accumulating at 2, 4, and 6 h after 
thioglycollate injection in ESAM−/− and ESAM+/+ mice 
  revealed a strong reduction by 70% (±4.5%) of neutrophil 
emigration at 2 h (Fig. 2 B). At later time points leukocyte 
accumulation in ESAM−/− mice recovered, resulting in even 
more neutrophils at the 6-h time point in ESAM−/− mice 
than in ESAM+/+ mice. Similar results as shown here for 
mice backcrossed with C57BL/6 mice for four generations 
were also obtained with mice backcrossed for eight genera-
tions (not depicted). We conclude that the lack of ESAM 
impairs neutrophil extravasation, leading to a delay of the 
  extravasation process shifting the peak of neutrophil accumu-
lation to a later time point.
We wanted to test whether ESAM would also be 
  dispensable for the extravasation of lymphocytes in a tissue 
and at a time point where and when neutrophils do require 
ESAM. Because neutrophils usually enter infl  amed sites ear-
lier than lymphocytes, we created an artifi  cial situation and 
stimulated mice i.p. with IL-1β as well as with the chemo-
kine CCL19 (MIP-3β). As shown in Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20060565/DC1, 
neutrophils and CD4+ lymphocytes were recruited at the 2-h 
time point; however, only the number of recruited neutro-
phils, but not the number of artifi  cially recruited, CCL19-
  responsive lymphocytes was reduced in ESAM−/− mice.
Figure 1.  Targeted disruption of the ESAM gene in mice. (A) Targeting 
strategy. A map of the relevant genomic region containing the first 
ATG-containing and the following six exons of ESAM (top), the targeting 
construct (middle), and the mutated locus after recombination (bottom) 
are shown. P1, P2, and P3 represent oligonucleotides used for PCR 
screening. The “external” probe used for Southern screening is depicted as 
a small bar. The 16.2- and 7.3-kb Southern fragments obtained for the WT 
or the mutated allele upon EcoRV (E) digestion, respectively, are depicted 
at the top and the bottom. (B) Detection of WT and targeted alleles by 
Southern blot analysis. Genomic DNA of mice of the F1 generation was 
digested with EcoRV. (C) PCR genotyping using primers P1, P2, and P3 
resulted in 225- or 538-bp products for the mutant or WT allele, respec-
tively. (D) Western blot of SDS-urea extracts of lung or heart tissue 
(as indicated) of adult mice of the three different genotypes with poly-
clonal antibody against mouse ESAM.JEM VOL. 203, July 10, 2006  1673
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Because PECAM-1 is also known to mediate extrava-
sation of neutrophils, but not of lymphocytes (1), we tested 
whether the contribution of PECAM-1 to this process would 
be dependent or independent of ESAM. As shown in Fig. 
S2, available at http://www.jem.org/cgi/content/full/jem.
20060565/DC1, blocking PECAM-1 with antibodies clearly 
reduced neutrophil recruitment in WT C57BL/6 mice and 
in ESAM−/− mice to the same extent, indicating that the 
role of PECAM-1 in neutrophil extravasation is independent 
of ESAM.
ESAM on platelets is not involved in the contribution 
of platelets to neutrophil extravasation
Platelets represent the only other cell type besides endothelial 
cells that express ESAM. Because ESAM has been reported 
to mediate homotypic cell binding (5, 8) and because plate-
lets participate in leukocyte extravasation as mediators of 
  leukocyte–endothelial interactions, it seemed plausible that 
ESAM on platelets would be involved in leukocyte extrava-
sation. To clarify this, we tested the eff  ect of platelet deple-
tion on the accumulation of neutrophils in the infl  amed 
peritoneum of ESAM+/+ and ESAM−/− mice. As shown in 
Fig. 2 D, antibodies against GP1bα very effi   ciently reduced 
the number of platelets by 98% (±1%), whereas peripheral 
white blood cell counts were not signifi  cantly reduced. Platelet 
depletion inhibited neutrophil recruitment into infl  amed 
peritoneum of ESAM+/+ mice by 41% (±20%; Fig. 2 C), 
clearly demonstrating the important role of platelets in neu-
trophil extravasation at this early time point. Interestingly, 
the same extent of inhibition was caused by the defi  ciency of 
ESAM. However, this reduced level of neutrophil recruit-
ment was further reduced by 55% (±13%) if platelets were 
depleted in ESAM−/− mice (Fig. 2 C). Thus, platelets con-
tribute to the process of neutrophil extravasation to a similar 
extent in ESAM+/+ mice as in ESAM−/− mice, demonstrat-
ing that ESAM is not required for the participation of plate-
lets in this process. We conclude that it is not the lack 
of ESAM on platelets, but the lack of ESAM at endothelial 
tight junctions that is responsible for the reduction of 
  neutrophil extravasation.
ESAM mediates leukocyte extravasation in vivo at the 
level of transmigration
To determine whether ESAM is involved in the diapedesis 
process rather than in the docking and adherence of neutro-
phils to the inner surface of the blood vessel wall, we visual-
ized leukocyte extravasation in the cremaster muscle. When 
mice were stimulated intrascrotally with TNF-α for 4 h 
  before microscopical analysis, we found a reduction of extra-
vasated leukocytes by almost 50% in ESAM−/− mice when 
Figure 2.  Role of ESAM in neutrophil, but not lymphocyte, extra-
vasation. (A) T cells from the lymph nodes of DNFB-sensitized donor 
mice were labeled with 51Cr and injected into the tail vein of sensitized 
and challenged ESAM+/+ or ESAM−/− mice (as indicated). After 5 (gray 
bars) and 15 h (black bars), radioactivity accumulated in the noninfl  amed 
(control) or DNFB-challenged ear (infl  amed) was calculated as percent of 
total injected radioactivity. (B) WT (+/+) or ESAM-defi  cient (−/−) mice 
were i.p. challenged with thioglycollate, and peritoneal neutrophils were 
counted 2, 4, or 6 h later. The data represent the mean ± SD of four or 
more mice in each group, and the depicted experiment represents one of 
three independent experiments with similar results. (C) ESAM+/+ (white 
bars) and ESAM−/− mice (black bars) were either injected i.v. with control 
antibodies (control) or with mAb against the platelet antigen GP1bα 
(depletion) to deplete platelets from the circulation. 24 h later, peripheral 
blood samples were analyzed for white and red blood cell and platelet 
counts (D) immediately followed by i.p. stimulation of mice with 
  thioglcollate. 2 h later, peritoneal neutrophils were counted. The data in B and 
C represent the mean ± SD of four or more mice in each group, and the 
depicted experiment represents one of three independent experiments 
with similar results. *, P < 0.05; ***, P < 0.001.1674  ESAM IS INVOLVED IN NEUTROPHIL DIAPEDESIS | Wegmann et al. 
compared with ESAM+/+ mice (Fig. 3, D and E). In con-
trast, no significant difference between the two geno-
types was observed in the number of adherent or rolling 
cells (Fig. 3, B, C, and E). Similar results were found if mice 
were stimulated for 4 h with IL-1β. The number of extrava-
sated leukocytes was reduced by 45% in ESAM−/− mice 
compared with ESAM+/+ mice, and no signifi  cant diff  erence 
was found in the number of rolling and adherent cells (Fig. 3 E). 
To rule out that the diff  erence in extravasation could be 
caused by diff  erences in leukocyte rolling or adhesion at an 
earlier time point during the 4-h period of cytokine stimula-
tion, we stimulated mice for only 2 h with IL-1β before the 
analysis. Leukocyte extravasation was just starting at this time 
point, whereas leukocyte rolling and adherence was already 
well detectable and again was not diff  erent between the two 
genotypes (not depicted). We conclude that the absence of 
Figure 3.  Intravital microscopy of TNF-𝗂–stimulated cremaster 
muscle: neutrophil extravasation is reduced in ESAM−/− mice. 
(A) Refl  ected light oblique transillumination microscopic image of a 
venule of the mouse cremaster muscle, demarcations on each side of 
the venule determine the areas in which extravasated leukocytes were 
counted. (B) Rolling fl  ux fraction. (C) Number of adhering leukocytes 
per 104 μm2 of venule surface area. (D) Numbers of extravasated 
  leukocytes in cremasteric venules of TNF-α–treated ESAM+/+ and 
ESAM−/− mice per 1.5 × 104 μm2 tissue area. The measurements 
were performed 4 h after intrascrotal TNF-α injection. n = 7 for each 
group; *, P < 0.05 versus ESAM+/+. (E) Quantitation of the intravital 
microscopy results.JEM VOL. 203, July 10, 2006  1675
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ESAM aff  ects leukocyte extravasation on the level of transen-
dothelial migration.
80% of extravasated cells upon TNF-α stimulation were 
positive for the granulocyte antigen Gr-1 as was determined 
by immunohistochemistry (not shown).
ESAM is involved in mechanisms regulating 
vascular permeability
To test whether the lack of ESAM would aff  ect the leakiness 
of blood vessels for molecules, we injected mice i.v. with the 
dye Evan’s blue and stimulated the peritoneum 15 min later 
for either 2 or 4 h with thioglycollate or for controls with 
PBS. As shown in Fig. 4 A, the leakiness for plasma protein–
adsorbed Evan’s blue was similar between ESAM+/+ and 
ESAM−/− mice in the absence of infl  ammation. Stimulation 
with thioglycollate increased the entry of Evan’s blue into in-
fl  amed peritoneum. However, similar to our results for the 
extravasation of neutrophils (Fig. 2 B), less dye had leaked 
out into the peritoneum in ESAM−/− mice than in ESAM+/+ 
mice at 2 h, whereas at 4 h, exit of dye molecules had 
  “recovered” in ESAM-defi  cient mice (Fig. 4 A). Thus, ESAM 
defi  ciency retards the increase of leakiness upon infl  amma-
tory stimulation in a similar way as it retards the extravasation 
of neutrophils. To analyze a potential role of ESAM in the 
regulation of endothelial permeability independent from 
  leukocyte extravasation, we again injected ESAM+/+ 
and ESAM−/− mice i.v. with Evan’s blue and stimulated 
them intradermally with VEGF165. Injected skin areas were 
excised from killed mice 15 and 30 min later, and the dye was 
extracted with formamide. As shown in Fig. 4 B, VEGF-
stimulated vascular permeability increased less strongly in 
ESAM−/− mice than in ESAM+/+ mice, suggesting that 
ESAM is indeed involved in signaling mechanisms that trig-
ger the opening of endothelial cell contacts.
The expression level and subcellular distribution pattern 
of other endothelial cell contact proteins, such as VE-
  cadherin, PECAM-1, and JAM-A, were unchanged in 
ESAM−/− mice as analyzed by quantitative immunoblot 
analysis of   kidney extracts (not depicted) and immunofl  uo-
rescence analysis of cryosections of brain, lung, and kidney, 
respectively (not depicted).
ESAM supports activation of the small GTPase Rho
Because small GTPases such as Rho and Rac1 have been 
  reported to aff  ect the stability of endothelial cell contacts, 
we tested whether the reduction of ESAM expression levels 
in cultured endothelial cells by RNAi would aff  ect the acti-
vation levels of these GTPases. Testing six diff  erent pairs of 
small interfering RNA (siRNA) oligonucleotides resulted in 
the identifi  cation of one pair that reduced the expression 
level of ESAM to 5% within 36 h of transfection of the siR-
NAs into mouse bEnd.3 endothelioma cells (Fig. 5, top). We 
found that this inhibition reduced the levels of activated Rho 
by 77% (±7%; three experiments quantitated) in these cells, 
Figure 4.  ESAM defi  ciency attenuates the increase of vascular 
permeability stimulated by infl  ammatory mediators as well as by 
VEGF. ESAM+/+ (white bars) and ESAM−/− mice (black bars) were i.v. in-
jected with Evan’s blue. (A) 15 min later, mice were i.p. injected with PBS 
or thioglycollate (as indicated) and either at 2 or 4 h after injection, the 
dye that had leaked into the peritoneum was quantifi  ed. (B) 10 min later, 
Evan’s blue–injected mice were intradermally injected with VEGF and killed 
after an additional 15 or 30 min (as indicated), and the dye was extracted 
from skin samples and quantifi  ed. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Figure 5.  Knocking down ESAM expression in endothelial cells by 
siRNA interferes with activation of Rho, but not of Rac1, Cdc42, 
and Rap1. The mouse endothelioma cell line bEnd.3 was transfected 
either with control siRNAs (control) or with siRNAs directed against 
ESAM (ESAM). 36 h later, cell lysates were immunoblotted for ESAM 
and as a negative control for β-catenin (top). Activation levels of various 
GTPases (as indicated on the side) were analyzed by pull-down experi-
ments with effector proteins followed by immunoblotting for the 
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whereas no eff  ects were seen on the levels of activated Rac1, 
Cdc42, or Rap1 (Fig. 5). Thus, the presence of ESAM sup-
ports signaling mechanisms that lead to the activation of Rho. 
Because activated Rho can lead to the destabilization of tight 
junctions (10, 11) and transendothelial migration of mono-
cytes and neutrophils have been reported to require active 
Rho and Rho kinase (12, 13), the infl  uence of ESAM on the 
activation of Rho could be involved in the mechanism by 
which ESAM supports neutrophil extravasation.
Concluding remarks
We have shown that ESAM is involved in the extravasation 
of neutrophils at an early step of the infl  ammatory process, 
whereas lymphocytes extravasate independently of ESAM. 
Although the detailed mechanism is unknown, several results 
reported here may lead the way toward understanding how 
ESAM functions. First, we found that ESAM is involved in 
the transmigration step, but not in the capturing and fi  rm ad-
hesion of neutrophils on the endothelial cell surface. Second, 
we could exclude a contribution of platelet-expressed ESAM 
and defi  ned the endothelial tight junction–associated ESAM 
as the relevant molecule in this process. Third, we found that 
the expression of ESAM supports the activation of the GT-
PAse Rho. This opens the intriguing possibility that ESAM 
may be involved in Rho-mediated signaling mechanisms that 
trigger the opening of endothelial cell contacts. It will be 
  important to elucidate how ESAM is stimulated in such 
a process. Direct binding of neutrophils to immobilized 
  recombinant ESAM or to ESAM-transfected cells could not 
be demonstrated (not depicted). Alternatively, ESAM could 
be involved in a signaling pathway where it could serve as a 
transmitter of signals from other endothelial receptors, which 
would trigger the destabilization of endothelial contacts. 
Fourth, the lack of ESAM does not only attenuate neutrophil 
extravasation, but also the increase in VEGF-triggered 
  permeability. This demonstrates that ESAM is relevant for 
the control of endothelial cell contacts beyond the process of 
leukocyte extravasation. Fifth, ESAM is involved in neutro-
phil extravasation mechanisms independent of the type of 
stimulating cytokine (TNF-α or IL-1β). This is in contrast to 
PECAM-1 and ICAM-2 because disrupting their genes in 
the C57BL/6 mouse strain aff  ects neutrophil extravasation only 
if IL-1β, but not if TNF-α, was used for stimulation (4, 14). 
Sixth, besides PECAM-1, ESAM is the second molecule at 
endothelial cell contacts that selectively aff  ects neutrophil, 
but not lymphocyte, extravasation. This hints toward interes t-
ing diff  erences between lymphocytes and neutrophils with 
respect to their way of overcoming the endothelial barrier.
Collectively, our results establish ESAM as a new membrane 
protein at endothelial junctions that is involved in neutrophil ex-
travasation and point toward a role of ESAM in signaling mecha-
nisms that trigger the opening of endothelial cell contacts.
MATERIALS AND METHODS
Antibodies. The following antibodies were used: mAb RB6-8C5 against 
Ly-6G and Ly-6C (Gr-1); FITC-conjugated monoclonal anti-CD4 and 
anti-CD8 antibodies (all from BD Biosciences); rat mAb RB40.34 against 
mouse P-selectin (15) and Mel14 against L-selectin (no. HB-132; American 
Type Culture Collection); 1G5.1 (IgG2b) and 5D2.6 (IgG2a), both against 
mouse PECAM-1 (unpublished data); isotype-matched negative control 
  antibodies; and a polyclonal rabbit antibody against mouse ESAM-Fc (8).
Peritonitis assay. For each assay, fi  ve 8–12-wk-old ESAM−/− mice and 
fi  ve sex-matched ESAM+/+ mice were used. Thioglycollate-induced perito-
nitis assays (induced by 1 ml of 3% thioglycollate broth) were essentially per-
formed as described previously (16), except that the peritoneal lavage was 
performed with 20 ml PBS containing 3 mM EDTA, the total cell counts 
were determined with a cell counter (CASY; Schärfe-System), and the per-
centage of neutrophils was determined by fl  ow cytometry (FACSCalibur; 
BD Biosciences) using the mAb RB6-8C5. Neutrophil numbers in perito-
neum increased 50-fold in 2 h over mock-stimulated mice. For kinetic stud-
ies, new animals were used for each time point. Alternatively to thioglycollate, 
10 ng IL-1β (Abazyme) was injected i.p. with 1 ml PBS. For antibody inhi-
bition, 50 μg/mouse was injected i.v. 15 min before administering IL-1β.
For lymphocyte recruitment into infl  amed peritoneum, mice were 
  injected i.p. with 10 ng IL-1β and 4 μg CCL19 (R&D Systems). Lympho-
cytes were determined by fl  ow cytometry using antibodies against CD4. 
Numbers of CD4+ T cells in the peritoneum were fourfold increased com-
pared with mock-stimulated mice.
Platelet depletion experiments. Platelet depletion was performed as de-
scribed previously (17). For each assay, fi  ve 8–12-wk-old ESAM−/− and fi  ve 
sex-matched ESAM+/+ mice were used. Mice were injected i.v. with 80 μg 
rat mAb (in 200 μl PBS) against mouse GpIbα (CD42b) or with the same 
amount of isotype-matched control rat IgG, both obtained from Emfret 
  Analytics. 24 h later, blood was collected from the retro-orbital plexus (under 
brief ether anesthesia) using heparinized microcapillaries (50 μl) treated with 
0.1 mol/L sodium citrate. Blood was immediately collected in a tube con-
taining 10% (vol/vol) 0.1 mol/L sodium citrate and then diluted with cold 
PBS. Platelets and white blood cells were counted with an automated cell 
counter (KX-21) from Sysmex. Shortly after bleeding, mice were challenged 
i.p. with thioglycollate, and neutrophil recruitment was determined as 
  described above.
Blood vessel permeability assays. The permeability of blood vessels was 
analyzed essentially as described previously (18). Evan’s blue leaking into the 
peritoneal cavity was measured after peritoneal challenge with either 1 ml 
3% thioglycollate broth or 1 ml PBS. For each assay, fi  ve 7–10-wk-old 
ESAM−/− or ESAM+/+ mice were used.
Modifi   ed Miles assay for VEGF165 (PeproTech)-stimulated vascular 
  permeability in the skin was described previously (19). For each assay, three 
8–12-wk-old ESAM−/− and three sex-matched ESAM+/+ mice were used. 
In brief, Evan’s blue dye (Sigma-Aldrich) was injected into the tail vein (100 μl 
of a 1% solution in PBS), and 10 min later, 50 μl PBS or mouse VEGF165 
(100 ng in 50 μl PBS) was intradermally injected into the shaved back skin. 
15 or 30 min later, skin areas were excised and extracted with formamide for 
5 d and the dye was measured at 620 nm. To exclude that the increase of 
Evan’s blue simply refl  ected the increase in blood fl  ow, we measured the 
quantity of hemoglobin in the tissue by noninvasive white light spectroscopy 
using an O2C spectroscopy device (LEA Medizintechnik). The quantity of 
hemoglobin in the VEGF-injected skin only increased by  20%.
Intravital microscopy. Surgical preparation of cremaster muscles and 
  intravital microscopy were essentially done as described previously (20). 
  Infl  ammatory stimulation was achieved by intrascrotal injection of 500 ng 
of recombinant murine TNF-α or 50 ng of recombinant murine IL-1β 
(R&D Systems) diluted in 0.3 ml PBS, administered to either ESAM+/+ 
or ESAM−/− mice 4 or 2 h (the latter only for IL-1β) before microscopic 
observation (n = 7 for each group). In each animal, three to fi  ve single 
  unbranched postcapillary venules with diameters of 17.5 to 35 μm were 
  analyzed. During a 15-min observation period, leukocyte rolling, adhesion, 
and extravasation were assessed by refl  ected light oblique transillumination JEM VOL. 203, July 10, 2006  1677
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microscopy. Videotaped images were evaluated off  -line using CAPIMAGE 
software (Zeintl). Leukocyte rolling fl  ux fraction is defi  ned as the fl  ux of 
rolling leukocytes in percent of total leukocyte fl  ux. The total number of 
adherent leukocytes was determined for each venule segment (100 μm) and 
is expressed per 104 μm2 of venule surface area. Emigrated cells were counted 
in an area reaching out 75 μm to each side of a vessel over a distance of 100-μm 
vessel length and are presented per 1.5 × 104 μm2 tissue area. Centerline 
blood fl  ow velocity was measured by using intra    -arterial–administered mi-
crospheres (0.96 μm; FluoSpheres; Invitrogen). The Newtonian wall shear 
rate [s−1] was estimated as 8 x [Vb /d], where Vb is the mean blood fl  ow 
  velocity and d is the diameter of the vessel. Mean blood velocity, Vb, was 
approximated by multiplying the centerline blood velocity by 0.625. The 
interfacial shear rate is the slope of the velocity profi  le at the interface of the 
endothelial surface layer and the vessel lumen, and it was calculated as 4.9 × 
8 x [Vb/d], where 4.9 is a mean empirical correction factor (21). Statistical 
analysis was done with the Mann-Whitney rank sum test, and p-values of 
<0.05 were considered signifi  cant.
All animal experiments were performed in accordance with the local 
animal protection legislation (Bezirksregierung Muenster).
Online supplemental material. Fig. S1 demonstrates that the lack of ESAM 
impairs neutrophil, but not lymphocyte recruitment, into IL-1β/CCL19-
stimulated peritoneum. Fig. S2 shows that antibodies against PECAM-1 
block neutrophil recruitment independent of ESAM. Figs. S1 and S2 as well 
as supplemental Material and methods are available at http://www.jem.org/
cgi/content/full/jem.20060565/DC1.
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